Patients with ECOG performance status of 1 reported worse global health status, quality of life, and physical functioning than those with a status of 0. The RATIONALE-305 trial showed Tevimbra plus ...
Incorporating ICIs into platinum-doublet regimens improved OS and ORR in ES-SCLC patients with ECOG PS 2 to 3, but not in those with ECOG PS 0 to 1. The study found manageable adverse reactions, with ...
In the companion to this article, Dr Ruiz et al 5 conducted an analysis of two prospective studies using wearable accelerometer-based evaluations to define patients' fitness through a new score known ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results